Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. (LLBO) Stock Overview
Explore Lifeline Biotechnologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3M
P/E Ratio
-52.21
EPS (TTM)
N/A
ROE
0.00%
LLBO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Lifeline Biotechnologies, Inc. (LLBO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -52.21 and a market capitalization of 3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.